Viking Therapeutics, Inc.
USD40.76
+1.22 (+3.10%)
CEO
Brian Lian
IPO Date
2015-04-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$39.50
Prev. Close
$39.54
Day Low
$39.08
Day High
$41.38
52W Low
$22.96
52W High
$43.15
Market Cap
$4.73B
Volume
1.87M
| -39.9 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -24.7% | -23.3% | 0.00 | 19.19 | -20.4 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -47.4% | -40.9% | 0.01 | 7.61 | -10.5 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -27.2% | -26.1% | 0.00 | 23.98 | -6.5 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -16.2% | -15.4% | 0.00 | 21.11 | -10.3 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -9.3% | -9.1% | 0.00 | 41.83 | -22.4 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -7.4% | -7.3% | 0.00 | 66.40 | -20.0 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -152.8% | -93.0% | 0.26 | 2.52 | -5.1 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -183.2% | -101.3% | 0.41 | 2.16 | -1.3 |
| -6.4 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -12.7% | -12.3% | 0.00 | 28.34 | -8.1 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -8.2% | -7.9% | 0.00 | 25.86 | -11.3 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -5.4% | -5.3% | 0.00 | 44.25 | -14.8 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -4.0% | -3.9% | 0.00 | 33.09 | -31.6 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -2.7% | -2.7% | 0.00 | 36.47 | -70.4 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -2.4% | -2.3% | 0.00 | 37.69 | -68.6 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -2.9% | -2.8% | 0.00 | 29.48 | -75.2 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -7.1% | -6.7% | 0.00 | 19.19 | -18.9 |